These ceRNAs can competitively inhibit the expression of miR-4443, comprising lncRNA FEZF1-AS1 in OS and HCC, lncRNA MNX1-AS1 in GBM, and lncRNA LINC00460 in head and neck squamous cell carcinoma (HNSCC). This evidence concerns the gene FEZF1 and hepatocellular carcinoma.